Pay attention to your fullness
Marty VN, Farokhnia M, Munier JJ, Mulpuri Y, Leggio L, Spigelman I
This means early use of GLP-1 and SGLT2 inhibitors, especially in patients with established cardiovascular disease
The common factors among this group include having established strong exercise habits during treatment (particularly resistance training), having completely overhauled eating patterns with a focus on high-protein whole-food diets, gradual tapering rather than abrupt discontinuation, and having lost weight slowly enough for metabolic adaptation to partially recalibrate
The same physiology that drives these benefits, particularly delayed gastric emptying, also explains many of the complications seen in the ED
No reduction in cravings